Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Posch · SciRah

Researcher profile · Semantic Scholar

M. Posch

Share profile

M. Posch — researcher profile on SciRah

h-index: 48
Works: 205
Citations: 8,180

Most-cited papers

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.
F. Eskandary, H. Regele, L. Baumann, G. Bond +13 more
2017Journal of the American Society of Nephrology259 citations Open access
Semantic Scholar
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study.
A. Avidan, C. Sprung, J. Schefold, B. Ricou +43 more
2021The Lancet Respiratory Medicine125 citations
Semantic Scholar
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.
E. Meyer, P. Mesenbrink, C. Dunger-Baldauf, H. Fülle +4 more
2020Clinical Therapeutics119 citations Open access
Semantic Scholar
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
Thomas Ondra, A. Dmitrienko, T. Friede, A. Graf +3 more
2016Journal of Biopharmaceutical Statistics115 citations Open access
Semantic Scholar
The use of external controls: To what extent can it currently be recommended?
H. Burger, C. Gerlinger, C. Harbron, A. Koch +3 more
2021Pharmaceutical statistics80 citations Open access
Semantic Scholar
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials
O. Collignon, Christian Gartner, A. Haidich, Robert James Hemmings +6 more
2020Clinical pharmacology and therapy79 citations
Semantic Scholar
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
N. Stallard, L. Hampson, N. Benda, W. Brannath +13 more
2020Statistics in Biopharmaceutical Research71 citations Open access
Semantic Scholar
An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis
Peter Bauer, J. Brugger, Franz König, M. Posch
2021Scientific Reports61 citations Open access
Semantic Scholar
On model-based time trend adjustments in platform trials with non-concurrent controls
Marta Bofill Roig, P. Krotka, C. Burman, E. Glimm +8 more
2021BMC Medical Research Methodology58 citations Open access
Semantic Scholar
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
C. Pontes, J. Fontanet, R. Vives, Aranzazu Sancho +10 more
2018Orphanet Journal of Rare Diseases57 citations Open access
Semantic Scholar
Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov
S. Hee, Adrian Willis, Catrin Tudur Smith, S. Day +5 more
2017Orphanet Journal of Rare Diseases55 citations Open access
Semantic Scholar
Methods for the analysis of multiple endpoints in small populations: A review
R. Ristl, Susanne Urach, G. Rosenkranz, M. Posch
2018Journal of Biopharmaceutical Statistics54 citations Open access
Semantic Scholar
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
Dominic Magirr, T. Jaki, F. Koenig, M. Posch
2016PLoS ONE50 citations Open access
Semantic Scholar
Subgroup identification in clinical trials via the predicted individual treatment effect
Nicolás M Ballarini, G. Rosenkranz, T. Jaki, Franz König +1 more
2018PLoS ONE47 citations Open access
Semantic Scholar
Optimized adaptive enrichment designs
Thomas Ondra, Sebastian Jobjornsson, R. Beckman, C. Burman +3 more
2017Statistical Methods in Medical Research45 citations Open access
Semantic Scholar
Recent advances in methodology for clinical trials in small populations: the InSPiRe project
T. Friede, M. Posch, S. Zohar, C. Alberti +18 more
2018Orphanet Journal of Rare Diseases41 citations Open access
Semantic Scholar
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
O. Collignon, F. Koenig, A. Koch, R. Hemmings +4 more
2018Trials37 citations Open access
Semantic Scholar
Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome
O. Collignon, C. Burman, M. Posch, A. Schiel
2021Clinical pharmacology and therapy33 citations Open access
Semantic Scholar
Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology
R. Ristl, Nicolás M Ballarini, Heiko Götte, Armin Schüler +2 more
2020Pharmaceutical statistics33 citations Open access
Semantic Scholar
Methods for non-proportional hazards in clinical trials: A systematic review
M. Bardo, C. Huber, N. Benda, J. Brugger +12 more
2023Statistical Methods in Medical Research32 citations Open access
Semantic Scholar
Marketing authorisation of orphan medicines in Europe from 2000 to 2013.
Matthias P. Hofer, Hanna Hedman, M. Mavris, F. Koenig +5 more
2017Drug Discovery Today32 citations Open access
Semantic Scholar
Determination of the optimal sample size for a clinical trial accounting for the population size
N. Stallard, Frank Miller, S. Day, S. Hee +3 more
2016Biometrical journal. Biometrische Zeitschrift31 citations Open access
Semantic Scholar
Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion
R. Sridhara, Olga Marchenko, Qi Jiang, R. Pazdur +13 more
2021Statistics in Biopharmaceutical Research27 citations Open access
Semantic Scholar
Design and estimation in clinical trials with subpopulation selection
Y. Chiu, F. Koenig, M. Posch, T. Jaki
2018Statistics in Medicine27 citations Open access
Semantic Scholar
Optimizing Trial Designs for Targeted Therapies
Thomas Ondra, Sebastian Jobjornsson, R. Beckman, C. Burman +3 more
2016PLoS ONE27 citations Open access
Semantic Scholar
Evidence, eminence and extrapolation
Gerald Hlavin, F. Koenig, C. Male, M. Posch +1 more
2016Statistics in Medicine26 citations Open access
Semantic Scholar
Online control of the False Discovery Rate in group-sequential platform trials
S. Zehetmayer, M. Posch, F. Koenig
2021Statistical Methods in Medical Research25 citations Open access
Semantic Scholar
Sex Differences in Kidney Transplantation: Austria and the United States, 1978–2018
Sebastian Hödlmoser, T. Gehrig, M. Antlanger, Amelie Kurnikowski +14 more
2022Frontiers in Medicine23 citations Open access
Semantic Scholar
Statistical analysis of Goal Attainment Scaling endpoints in randomised trials
Susanne Urach, C. M. W. Gaasterland, M. Posch, B. Jilma +4 more
2018Statistical Methods in Medical Research23 citations Open access
Semantic Scholar
Approaches to sample size calculation for clinical trials in rare diseases
Frank Miller, S. Zohar, N. Stallard, J. Madan +5 more
2018Pharmaceutical statistics22 citations Open access
Semantic Scholar
Platform trials and the future of evaluating therapeutic behavioural interventions
S. Gold, Marta Bofill Roig, J. Miranda, C. Pariante +2 more
2022Nature Reviews Psychology21 citations
Semantic Scholar
Analysis of Austrian COVID-19 deaths by age and sex
M. Posch, P. Bauer, A. Posch, Franz König
2020Wiener Klinische Wochenschrift21 citations Open access
Semantic Scholar
Weekends affect mortality risk and chance of discharge in critically ill patients: a retrospective study in the Austrian registry for intensive care
P. Zajic, P. Bauer, A. Rhodes, R. Moreno +5 more
2017Critical Care21 citations Open access
Semantic Scholar
Evaluation and calibration of SAPS 3 in patients with COVID-19 admitted to intensive care units
P. Metnitz, R. Moreno, T. Fellinger, M. Posch +1 more
2021Intensive Care Medicine20 citations Open access
Semantic Scholar
Implementing clinical trial data sharing requires training a new generation of biomedical researchers
U. Mansmann, C. Locher, F. Prasser, T. Weissgerber +11 more
2023Nature Medicine19 citations Open access
Semantic Scholar
Online error rate control for platform trials
David S. Robertson, J. Wason, Franz König, M. Posch +1 more
2023Statistics in Medicine19 citations Open access
Semantic Scholar
Conformal prediction intervals for the individual treatment effect
D. Kivaranovic, R. Ristl, M. Posch, H. Leeb
202019 citations
Semantic Scholar
Robustness of testing procedures for confirmatory subpopulation analyses based on a continuous biomarker
A. Graf, G. Wassmer, T. Friede, Roland G Gera +1 more
2018Statistical Methods in Medical Research19 citations Open access
Semantic Scholar
Simultaneous inference for multiple marginal generalized estimating equation models
R. Ristl, L. Hothorn, C. Ritz, M. Posch
2019Statistical Methods in Medical Research18 citations Open access
Semantic Scholar
Estimands and Complex Innovative Designs
O. Collignon, A. Schiel, C. Burman, K. Rufibach +2 more
2022Clinical pharmacology and therapy16 citations Open access
Semantic Scholar
A critical review of graphics for subgroup analyses in clinical trials
Nicolás M Ballarini, Y. Chiu, Franz König, M. Posch +1 more
2020Pharmaceutical statistics16 citations Open access
Semantic Scholar
Applicability and added value of novel methods to improve drug development in rare diseases
M. Mitroiu, K. Rengerink, C. Pontes, Aranzazu Sancho +14 more
2018Orphanet Journal of Rare Diseases16 citations Open access
Semantic Scholar
Fallback tests for co‐primary endpoints
R. Ristl, F. Frommlet, A. Koch, M. Posch
2016Statistics in Medicine16 citations Open access
Semantic Scholar
Comparing maximum diameter and volume when assessing the growth of small abdominal aortic aneurysms using longitudinal CTA data: cohort study
R. Ristl, J. Klopf, Andreas Scheuba, A. Sotir +7 more
2023International Journal of Surgery15 citations Open access
Semantic Scholar
Impact of adaptive filtering on power and false discovery rate in RNA-seq experiments
S. Zehetmayer, M. Posch, A. Graf
2022BMC Bioinformatics14 citations Open access
Semantic Scholar
Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs
Nicolás M Ballarini, T. Burnett, T. Jaki, Christoper Jennison +2 more
2021Statistics in Medicine14 citations Open access
Semantic Scholar
Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
Michal Hledík, Jitka Polechová, M. Beiglböck, A. Herdina +2 more
2021PLoS ONE14 citations Open access
Semantic Scholar
Optimal exact tests for multiple binary endpoints
R. Ristl, Dong Xi, E. Glimm, M. Posch
2016Computational Statistics & Data Analysis14 citations Open access
Semantic Scholar
Nested combination tests with a time‐to‐event endpoint using a short‐term endpoint for design adaptations
S. Jörgens, G. Wassmer, Franz König, M. Posch
2019Pharmaceutical statistics13 citations
Semantic Scholar
Value of information methods to design a clinical trial in a small population to optimise a health economic utility function
Michael Pearce, S. Hee, J. Madan, M. Posch +4 more
2018BMC Medical Research Methodology13 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Ristl×11
Invite
R. Ristl — researcher profile on SciRah
N. Stallard×9
Invite
N. Stallard — researcher profile on SciRah
F. Koenig×8
Invite
F. Koenig — researcher profile on SciRah
Franz König×7
Invite
Franz König — researcher profile on SciRah

×6

Invite

Frank Miller — researcher profile on SciRah

Invite

T. Jaki — researcher profile on SciRah

Invite

A. Koch — researcher profile on SciRah

Invite

K. Roes — researcher profile on SciRah

Invite

C. Burman — researcher profile on SciRah

Invite

S. Hee — researcher profile on SciRah

Invite

S. Day — researcher profile on SciRah

Invite

J. Madan — researcher profile on SciRah